Chaparral-associated hepatotoxicity

Archives of Internal Medicine

Volumn 157, Issue 8, 1997, Pages 913-919

  Sheikh, Nasreen M ^a   Philen, Rossanne M ^b   Love, Lori A ^a  

^a U S DEPARTMENT OF AGRICULTURE   (United States)

^b NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CHAPARRAL; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ARTICLE; BILIARY TRACT DISEASE; DIARRHEA; DIET SUPPLEMENTATION; FATIGUE; HUMAN; LIVER FAILURE; LIVER INJURY; LIVER TOXICITY; NAUSEA; PRIORITY JOURNAL; TEA;

EID: 0031403132     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.157.8.913     Document Type: Article

References (38)

1. Geubel AP, De Galocsy C, Alves N, Rahier J, Dive C. Liver damage caused by therapeutic vitamin A administration: estimate of dose-related toxicity in 41 cases. Gastroenterology. 1991;100:1701-1709.
2. Kowalski TE, Falestiny M, Furth E, Malet PF. Vitamin A hepatotoxicity: a cautionary note regarding 25,000 IU supplements. Am J Med. 1994;97:523-528.
3. Larrey D, Vial T, Pauwels A, et al. Hepatitis after germander (Teucrium chamaedrys) administration: another instance of herbal medicine hepatotoxicity. Ann Intern Med. 1992;117:129-132.
4. Woolf GM, Petrovic LM, Rojter SE, et al. Acute hepatitis associated with the Chinese herbal product jin bu huan. Ann Intern Med. 1994;121:729-735.
5. Centers for Disease Control and Prevention. Jin bu huan toxicity in adults - Los Angeles, 1993. MMWR Morb Mortal Wkly Rep. 1993;42:920-922.
6. Hebel SK, ed. Chaparral. St Louis, Mo: Facts and Comparisons; 1989:1-2. The Lawrence Review of Natural Products Monograph System.
7. Centers for Disease Control and Prevention. Chaparral-induced toxic hepatitis - California and Texas, 1992. MMWR Morb Mortal Wkly Rep. 1992;41:812-814.
8. Centers for Disease Control and Prevention. Chaparral-induced toxic hepatitis - California and Texas, 1992. JAMA. 1992;268:3295, 3298.
9. Katz M, Saibil F. Herbal hepatitis: subacute hepatic necrosis secondary to chaparral leaf. J Clin Gastroenterol. 1990;12:203-206.
10. Smith BC, Desmond PV. Acute hepatitis induced by ingestion of the herbal medication chaparral. Aust N Z J Med. 1993;23:526.
11. Alderman S, Kailas S, Goldfarb S, Singaram C, Malone DG. Cholestatic hepatitis after ingestion of chaparral leaf: confirmation by endoscopic retrograde cholangiopancreatography and liver biopsy. J Clin Gastroenterol. 1994;19:242-247.
12. Gordon DF, Rosenthal G, Hart J, Sirota R, Baker AL. Chaparral ingestion: the broadening spectrum of liver injury caused by herbal medications. JAMA. 1995; 273:489-490.
13. Obermeyer WR, Musser SM, Betz JM, Casey RE, Pohland AE, Page SW. Chemical studies of phytoestrogens in flax and chaparral (43824). Proc Soc Exp Biol Med. 1995;208:6-12.
14. Toft E, Vyberg M, Therkelsen K. Diltiazem-induced granulomatous hepatitis. Histopathology. 1991;18:474-475.
15. Sarachek NS, London RL, Matulewicz TJ. Diltiazem and granulomatous hepatitis. Gastroenterology. 1985;88:1260-1262.
16. Zimmerman HJ. Hepatotoxicity. Dis Mon. 1993;39:675-787.
17. Grimbert S, Pessayre D, Degott C, Benhamou JP. Acute hepatitis induced by HMG-CoA reductase inhibitor, lovastatin. Dig Dis Sci. 1994;39:2032-2033.
18. Huxtable RJ. The myth of beneficent nature: the risks of herbal preparations. Ann Intern Med 1992;117:165-166.
19. MacGregor FB, Abernethy VE, Dahabra S, Cobden I, Hayes PC. Hepatotoxicity of herbal remedies. BMJ. 1989;299:1156-1157.
20. Ridker PM, McDermott WV. Comfrey herb tea and hepatic veno-occlusive disease. Lancet. 1989;1:657-658.
21. Ridker PN, McDermont WV. Hepatotoxicity due to comfrey herb tea. Am J Med. 1989;87:701.
22. Roitman JN. Comfrey and liver damage. Lancet. 1981;1:944.
23. Stillman AE, Huxtable RJ, Fox D, Hart M, Bergeson P. Pyrrolizidine (Senecio) poisoning in Arizona: severe liver damage due to herbal teas. Ariz Med. 1977; 34:545-546.
24. Bach N, Thung SN, Schaffner F. Comfrey herb tea-induced hepatic venoocclusive disease. Am J Med. 1989;87:97-99.
25. Harvey J, Colin-Jones DG. Mistletoe hepatitis. BMJ. 1981;282:186-187.
26. Beuers U, Spengler U, Pape GR. Hepatitis after chronic abuse of senna. Lancet. 1991;337:372-373.
27. Salari H, Braquet P, Borgeat P. Comparative effects of indomethacin, acetylenic acids, 15-HETE, nordihydroguaiaretic acid and BW755C on the metabolism of arachidonic acid in human leukocytes and platelets. Prostaglandins Leukot Essent Fatty Acids. 1984;13:53-60.
28. Agarwal R, Wang ZY, Bik DP, Mukhtar H. Nordihydroguaiaretic acid, an inhibitor of lipoxygenase, also inhibits cytochrome P-450-mediated monooxygenase activity in rat epidermal and hepatic microsomes. Drug Metab Dispos. 1991;19:620-624.
29. Capdevila J, Gil L, Orellana M, et al. Inhibitors of cytochrome P-450-dependent arachidonic acid metabolism. Arch Biochem Biophys. 1988;261: 257-263.
30. Konno C, Lu ZZ, Xue HZ, et al. Furanoid lignans$ from Larrea tridentata. J Nat Prod. 1990;53:396-406.
31. Tyler VE. Chaparral. In: The Honest Herbal. 3rd ed. New York, NY: Pharmaceutical Products Press: 1993:87-88.
32. De Smet PAGM. Larrea tridentata. Adv Effects Herb Drug. 1993;2:231-240.
33. Brinker F. Larrea tridentata (D.C.) Coville (chaparral or creosote bush). Br J Phytother. 1993/94;3:10-31.
34. 21 CFR §189.165 (1995).
35. Smith AY, Feddersen RM, Gardner KD Jr, Davis CJ. Cystic renal cell carcinoma and acquired renal cystic disease associated with consumption of chaparral tea: a case report. J Urol. 1994;152:2089-2091.
36. Goodman T, Grice HC, Becking GC, Salem FA. A cystic nephropathy induced by nordihydroguaiaretic acid in the rat: light and electron microscopic investigations. Lab Invest. 1970;23:93-107.
37. Philen RM, Ortiz DI, Auerbach SB, Falk H. Survey of advertising for nutritional supplements in health and bodybuilding magazines. JAMA. 1992;268:1008-1011.
38. Kessler DA. Introducing MEDWatch: a new approach to reporting medication and device adverse effects and product problems. JAMA. 1993;269:2765-2768.